American College of Clinical Pharmacy ®

Nationally recognized experts and practitioners in critical care pharmacy serve as the faculty for the Critical Care Pharmacy Course.

ACCP Spring Forum Preparatory
Review and Recertification Courses
April 23–24, 2022

Browse by Last Name | A | B | D | G | H | M | R | S | T | V | W |

Mahmoud Ammar, Pharm.D., FCCM, BCPS, BCCCP Shock Syndromes II: Hypovolemic, Critical Bleeding, and Obstructive Dr. Ammar is the Surgery-Trauma Critical Care pharmacist at Yale New Haven Hospital in New Haven, Connecticut, and the lead critical care pharmacist for the Yale New Haven Health System. Dr. Ammar is a clinical associate professor at the University of Connecticut School of Pharmacy. He also teaches didactic courses at the Yale School of Medicine Physician Associate Program. Dr. Ammar received his PharmD degree from Purdue University and completed his pharmacy practice residency at the Cleveland Clinic in Cleveland, Ohio, where he practiced as a critical care pharmacist prior to his transition to his current position at Yale New Haven Hospital.
Erin Frazee Barreto, Pharm.D., M.Sc., FCCM, FASN Acute Kidney Injury and Renal Replacement Therapy in the Critically Ill Patient Dr. Erin Barreto is an Associate Professor of Medicine and Pharmacy at Mayo Clinic and a critical care pharmacist. After finishing her Pharm.D. training at Drake University, Dr. Barreto completed her clinical pharmacy residencies at Mayo Clinic in Rochester, Minnesota. She subsequently earned her Masters in Clinical and Translational Science from the Mayo Graduate School and a 3-year tenure as a Kern Scholar in the Mayo Clinic Center for the Science of Health Care Delivery. Dr. Barreto is a federally-funded researcher, has authored or co-authored more than 90 peer-reviewed manuscripts and book chapters, and is a recognized expert in optimizing the safe and effective use of renally-eliminated and nephrotoxic medications. She is actively involved in several pharmacy and multiprofessional organizations and is a Fellow in the American College of Critical Care Medicine and in the American Society of Nephrology.
Stephanie Bass, Pharm.D., BCPS, BCCCP Hepatic Failure/GI/Endocrine Emergencies Dr. Stephanie Bass received her Pharm.D. from the University of North Carolina in 2011 and completed her PGY1 Pharmacy Practice Residency as well as her PGY2 Critical Care Residency at Cleveland Clinic. She currently practices in the Medical ICU at Cleveland Clinic in Cleveland, Ohio. She also has a specialized practice area in the Medical Liver Intensive care unit. Her research interests include pharmacology of acute liver failure and end-stage liver disease in critically ill patients, and infectious disease complications in the critically ill. She has authored or co-authored more than 25 peer-review publications and book chapters and has presented at regional and national conferences on topics including acute and end-stage liver disease and antimicrobial stewardship in the ICU.
Grace E. Benanti, Pharm.D., BCCCP Pulmonary Disorders II Dr. Grace Benanti is a board-certified Clinical Pharmacy Specialist in the Medical ICU at Banner – University Medical Center Phoenix. She completed her doctorate of pharmacy at St. Louis College of Pharmacy in 2015. She moved to Phoenix to complete a PGY-1 at Banner University Medical Center – Phoenix. She then completed a PGY-2 in critical care at The University of Texas MD Anderson Cancer Center and practiced for two years as an ICU pharmacist at The University of California Davis Medical Center. Her research interests include sedation/analgesia in the ICU and infectious disease.
Scott T. Benken, Pharm.D., FCCM, BCPS-AQ Cardiology Cardiovascular Critical Care II Dr. Scott T. Benken is a clinical pharmacist in the medical ICU at the University of Illinois Hospital & Health Sciences System in Chicago, Illinois, and a clinical assistant professor at the University of Illinois at Chicago College of Pharmacy. He received his Pharm.D. degree from the University of Cincinnati, James L. Winkle College of Pharmacy, in Cincinnati, Ohio. Thereafter, Dr. Benken completed residencies in pharmacy practice and critical care at the University of Illinois Hospital & Health Sciences System. Dr. Benken’s clinical and research interests involve the optimization of medication therapy in critically ill patients as well as the exploration of medication regimens in unique critically ill patient subsets. He enjoys collaborative research endeavors as well as experiential teaching; he especially appreciates didactic classroom opportunities throughout the pharmacy curriculum. Dr. Benken is board certified in pharmacotherapy, and in 2014, he joined the ACCP Critical Care Pharmacy Preparatory Review Course faculty. “I once heard surviving a sudden cardiac arrest described as “being given a second chance” or a survivor’s stating that “there must be something left to accomplish.” Whatever the perspective may be, having the knowledge and skills to participate in resuscitation and revival is crucial for every critical care pharmacist. Our patients deserve the best of what we know and can offer to make sudden cardiac arrest “something they will never remember, but also something they will never forget.””
Bradley A. Boucher, Pharm.D., FCCP, FNAP, MCCM Critical Care Pharmacy Evolution and Validation, Practice Standards, Training, and Professional Development Bradley A. Boucher is Professor of Clinical Pharmacy and Translational Science at the University of Tennessee Health Science Center (UTHSC) College of Pharmacy in Memphis, Tennessee. He formerly practiced in the area of critical care at Regional One Health. As an academician, Dr. Boucher has published 95 peer-reviewed articles and over 40 book chapters. As a mentor, he has precepted 9 fellows and 78 critical care residents. Dr. Boucher received his B.S. and Pharm.D. degrees from the University of Minnesota, Minneapolis, Minnesota, in 1979 and 1983, respectively. Thereafter in 1984, he completed an ASHP Critical Care Fellowship at the University of Kentucky in Lexington, Kentucky. He was elected as a Fellow of ACCP in 1998 and Master of Critical Care Medicine of the American College of Critical Care Medicine in 2015. He was among the first of six pharmacists to receive this latter distinction. In 2004, Dr. Boucher distinguished himself by being elected as a pharmacy member of the National Academy of Practitioners. In addition, Dr. Boucher received the 2011 ACCP Clinical Practice Award. In 2021, Dr. Boucher was the UTHSC faculty nominee for the UT President’s Award in the Educate category and the 2023 Optimism and Visionary category. Relative to professional service, Dr. Boucher served as the president of ACCP in 2002 and received the ACCP Service Award in 2004. In 2016-2018, Dr. Boucher served as the President of the National Rho Chi Honor Society. Currently, Dr. Boucher is serving as the Rho Chi Society Treasurer. “The specialty of critical care pharmacy has grown during the past half-century from consisting of a handful of visionary pharmacists practicing in a variety of critical care settings to becoming the standard of care for intensive care units in the United States. The leadership of the pioneering critical care pharmacists has not only led to the pharmacy profession’s formal recognition within the interdisciplinary world of critical care, but has also resulted in several studies documenting the value of critical care pharmacists relative to improving patient care. This ranges from a reduction in drug and overall medical costs, as well as adverse drug effects/drug interactions, to improvements in patient morbidity and mortality. The evolution of critical care pharmacy has been fueled by exponential growth in the training and credentialing of practitioners and researchers within this specialty area. The culmination of this growth is evidenced by BPS recognition of critical care pharmacy as a specialty in 2013. Framing the core knowledge base areas and skills needed for success as a critical care pharmacist is the focus of the newly crafted ACCP Critical Care Pharmacy Preparatory and Review Course.”
Mitchell Buckley, Pharm.D., FCCP, FCCM, FASHP, BCCCP Pulmonary Disorders I Dr. Buckley, PharmD, FCCP FASHP, FCCM, BCCCP, is a clinical pharmacy specialist in the medical ICU at Banner University Medical Center in Phoenix, AZ. Dr. Buckley received his Pharm.D. degree from the University of Iowa. He completed an ASHP-accredited PGY1 Pharmacy Practice Residency at Shawnee Mission Medical Center and a PGY2 Critical Care Specialty Residency at the University of Arizona. He has authored several peer-reviewed publications in pharmacy and medical journals as well as book chapters relating to critical care. He is actively involved in several professional organizations. He has served as Chair of the ACCP Critical Care PRN, SCCM CPP Patient Safety Committee, SCCM CPP Research Committee, and SCCM CPP Practice Advancement Committee as well as the ASHP Critical Care Network Facilitator. He was the recipient of the 2013 ACCP Critical Care PRN Member Research Grant, 2014 ASHP Best Practice Award, 2014 ACCP Critical Care PRN Leadership Award, 2015 SCCM CPP Section Excellence in Using Technology to Improve ICU Medication Safety Award, 2016 ASHP Foundation Literature Award in Pharmacy Practice Research, 2018 SCCM Barry A. Shapiro Memorial Award for Excellence in Critical Care Management, and 2021 ACCP Critical Care PRN Achievement Award. He is currently leading several multidisciplinary teams at his institution on several process improvement strategies and critical care pharmacy practice advancement initiatives. Dr. Buckley’s clinical and research interests include acute respiratory distress syndrome, septic shock, sedation/delirium management, and medication safety in ICU patients.
Mitchell J. Daley, Pharm.D., FCCM, BCCCP Shock Syndromes II: Hypovolemic, Critical Bleeding, and Obstructive Mitchell J. Daley is a market critical care clinical pharmacy specialist for Seton Healthcare Family in Austin, Texas. He provides direct patient care at Dell Seton Medical Center at the University of Texas in the trauma/surgical or medical ICU while supporting clinical administrative projects for the Seton Healthcare Network and Ascension Health. He completed his Pharm.D. degree at the University of Wyoming, followed by PGY1 pharmacy practice and PGY2 critical care pharmacy residencies at the University of Chicago Medicine. Thereafter, he obtained board certification in pharmacotherapy and holds a clinical adjunct faculty appointment with the University of Texas College of Pharmacy, where he precepts pharmacy residents and students in the adult ICU. Recently, he was inducted as a fellow with the American College of Critical Care Medicine. Daley’s scholarly interests include thrombolysis in acute pulmonary embolism, anticoagulation reversal in life-threatening hemorrhage, circulatory shock, pharmacotherapy in the trauma ICU, and the impact of medications on thromboelastography. He has presented on and published numerous research and reviews related to this subject material and currently co-leads the management of shock syndromes for the ACCP review course for board preparation. In addition, he has led efforts to optimize patient outcomes related to thrombolytics in pulmonary embolism, management of septic shock, anticoagulation/antiplatelet reversal, and pharmacotherapy in massive transfusion protocol across the Seton Healthcare Network. He is a member of the ACCP Critical Care PRN and the Society of Critical Care Medicine Clinical Pharmacy and Pharmacology section. He is a past chair of the SCCM CPP Research Committee and currently serves as a taskforce member of the ACCP/SCCM critical care pharmacy services position statement.
Stephanie Dwyer Kaluzna, Pharm.D., BCCP Cardiovascular Critical Care I Dr. Stephanie Dwyer Kaluzna is a Cardiovascular Clinical Pharmacist at the University of Illinois Hospital and Health Sciences System and a Clinical Assistant Professor at the University of Illinois at Chicago (UIC) College of Pharmacy (COP). She is also the residency program director for the PGY2 Cardiology Residency Program at UIC. Dr. Dwyer Kaluzna received her PharmD from UIC COP, where she studied at the Rockford campus. She completed her PGY1 at the Captain James A. Lovell Federal Health Care Center and her PGY2 Cardiology Residency at UIC. Within cardiology, her areas of interest include heart failure, antithrombotic therapy, arrhythmias, valvular disease, and transitions of care.
Gabrielle Gibson, Pharm.D., BCPS, BCCCP Infectious Diseases II Dr. Gabrielle Gibson received her Pharm.D. from the University of Michigan in 2012 and completed her PGY1 Pharmacy Practice Residency as well as her PGY2 Critical Care Residency at the Cleveland Clinic. She currently practices in the Surgical/Trauma/Burn ICU at Barnes-Jewish Hospital in St. Louis, Missouri. Her research interests include anticoagulation reversal in life-threatening bleeding, optimization of anticoagulation practices in the trauma population, and infectious diseases in the critically ill patient population.
Jaime Robenolt Gray, Pharm.D., FCCM, BCCCP Practice Administration and Development: Protocol Development and Quality Improvement Dr. Jaime Robenolt Gray is the System Director of Medication Safety and Policy at the Temple University Health System, Philadelphia, Pennsylvania. Dr. Gray also serves as the PGY1 Residency Coordinator at Temple University Hospital – Main Campus. Dr. Gray graduated with a B.S. in Biology from James Madison University and Doctor of Pharmacy from Virginia Commonwealth University. She completed a PGY1 Pharmacy Residency at the University of Maryland Medical Center, Baltimore, MD and PGY2 Critical Care Residency at Detroit Medical Center, Detroit, MI. Dr. Gray served as a surgical ICU Clinical Pharmacy Specialist in Surgery/Trauma, Neuro Critical Care, and Cardiothoracic Surgery Critical Care for 10 years at the Hospital of the University of Pennsylvania (HUP). Additionally, she served as PGY2 Critical Care RPD for 8 years at HUP. Dr. Gray is a Fellow of Critical Care Medicine and a Board-Certified Critical Care Pharmacist. She recently was the recipient of the ACCP Critical Care PRN Member Professional Development Scholarship to pursue her Medication Safety Certification (2021). Dr. Gray has written book chapters for Pharmacotherapy Casebook and ACCP Pharmacotherapy Self-Assessment Program. She is an active member of multiple organizations including SCCM CPP Committee where she serves as a charge lead for the CPP Patient Safety quarterly newsletter, ACCP Crit Care PRN, ASHP, and Medication Safety Officers Society. Her areas of interest include transitions of care, quality improvement, medication safety, sepsis, pain/agitation/delirium, alcohol withdrawal, intracranial hypertension, and antimicrobial stewardship.
Curtis E. Haas, Pharm.D., FCCP Critical Care Pharmacy Evolution and Validation, Practice Standards, Training, and Professional Development Curtis Haas is the chief pharmacy officer for the University of Rochester Medical Center (URMC) in Rochester, New York. He received his B.S. degree from the Albany College of Pharmacy in Albany, New York, in 1982, and completed his Pharm.D. degree at the University at Buffalo in Buffalo, New York, in 1989. Haas spent the first 18 years of his professional career in the acute care environment, progressing through many clinical, administrative, and research responsibilities ranging from a staff pharmacist to the director of the Clinical Pharmacology Trials Unit. In 2000, he joined the faculty at the School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, where he was eventually promoted to an associate professor with tenure. In 2006, Haas accepted his current position at URMC. For 17 years, he specialized in critical care pharmacy practice and maintained an active teaching, practice, and research program. His many professional service activities include ACCP past president and board member and appointment to the Pharmacotherapy Specialty Council of the Board of Pharmacy Specialties. He has been involved in the training and education of pharmacy students, residents, and fellows for more than 20 years.
Lisa Hall Zimmerman, Pharm.D., FCCM, FCCP, BCPS, BCNSP, BCCCP Practice Administration and Development: Protocol Development and Quality Improvement Dr. Lisa Hall Zimmerman serves as a Clinical Pharmacist Specialist at Beaumont Hospital in Royal Oak, Michigan. She also serves as an Adjunct Assistant Professor of Pharmacy Practice with Wayne State University, Eugene Applebaum College of Pharmacy and Health Sciences in Detroit, Michigan. Dr. Hall Zimmerman graduated with a BS in Pharmacy from Auburn University, Doctor of Pharmacy from Samford University, and a PGY2 Critical Care Pharmacy Residency from Mayo Clinic in Rochester, Minnesota. She has served as a residency program director three residencies: the PGY2 Critical Care (2005-2013), the PGY2 Emergency Medicine (2010-2012) at Detroit Receiving Hospital, Detroit, MI and the PGY2 Critical Care (2016-2019) at New Hanover Regional Medical Center in Wilmington, NC. Dr. Hall Zimmerman is a Fellow of Critical Care Medicine, a Fellow of the American College of Clinical Pharmacy, a Board-Certified Critical Care Pharmacist, a Board-Certified Pharmacotherapy Specialist, and a Board-Certified Nutrition Support Pharmacist. Dr. Hall Zimmerman has written and presented papers on infections in the critically ill, surgical infections, pain, nutrition/metabolic management, and vasopressin. Dr. Hall Zimmerman’s research interest include septic shock, hemodynamic support, infections in the critically ill, and surgery/trauma. “Topics with protocol development and quality assurance will cover how to develop, promote, and justify critical care pharmacy services as well as how to design protocol, develop practice standards, and evaluate quality to promote best practice in the critical care environment. Other topics in this section include identifying the metrics for evaluating critical care pharmacy services and national quality programs.”
Eric W. Mueller, Pharm.D., FCCP, FCCM Infectious Diseases I Dr. Eric W. Mueller is the assistant director of clinical pharmacy services and research at the University of Cincinnati Medical Center (UCMC) and an adjunct associate professor of pharmacy practice at the University of Cincinnati, Cincinnati, Ohio. Dr. Mueller has practiced as a clinical pharmacy specialist in critical care at UCMC since 2005. Dr. Mueller also serves as the director of the PGY2 critical care pharmacy residency program. Dr. Mueller received his B.S. (1999) and Pharm.D. (2001) degrees from the University of Cincinnati and completed his critical care/nutrition support residency (2002) and critical care research fellowship (2004) at the University of Tennessee Health Science Center in Memphis, Tennessee. Dr. Mueller’s interdisciplinary clinical practice is primarily in critically ill surgical/trauma and medical patients. Dr. Mueller’s main clinical research interests and productivity are in infectious disease, pharmacokinetics/pharmacodynamics, anticoagulation, patient comfort, and outcome-driven process improvement. Dr. Mueller serves as a preceptor for PGY1 and PGY2 pharmacy residents and APPE students, and he is an interdisciplinary educator for critical care nurses and physicians. Dr. Mueller is active in pharmacy and critical care–related professional organizations, including service in leadership roles in ACCP, the Society of Critical Care Medicine, and American Society of Health-System Pharmacists.
Sara Radparvar, Pharm.D., BCPS, BCCCP Supportive and Preventive Medicine Dr. Sara Radparvar received her PharmD from Rutgers University, Ernest Mario School of Pharmacy and subsequently completed a PGY1 and PGY2 critical care pharmacy residency at UMass Memorial Medical Center in Worcester, Massachusetts. Before joining the Mount Sinai Heath System, she served as a clinical assistant professor at Rutgers University, Ernest Mario School of Pharmacy and a critical care clinical pharmacist at RWJ-Barnabas Health in Livingston, New Jersey. Currently, Dr. Radparvar is the residency program director for the PGY2 critical care pharmacy residency program at The Mount Sinai Hospital/Touro College of Pharmacy and practices in The Mount Sinai Hospital’s surgical and transplant intensive care units. She also volunteers in the hospital’s Critical Care Recovery Clinic and is an adjunct professor at the Phillips School of Nursing at Mount Sinai Beth Israel.
Gretchen Sacha, Pharm.D., BCCCP Shock Syndromes I: Introduction, Vasodilatory, and Sepsis Dr. Gretchen Sacha is a Clinical Pharmacy Specialist practicing in the Medical ICU at the Cleveland Clinic Main Campus. Gretchen received her B.S. in Pharmaceutical Sciences and Doctor of Pharmacy at the University of Toledo in 2014. She completed two years of post-graduate residency training at the Cleveland Clinic and received board-certification in Critical Care in 2016. Her clinical research areas of interest includes hemodynamics, septic shock, and vasoactive agents. She has authored or co-authored over 30 peer-reviewed publications and book chapters and has presented at regional and national conferences on topics including septic shock, refractory shock, and therapeutic strategies for vasodilatory shock. She joined the ACCP Critical Care Pharmacy Preparatory Review Course as faculty in 2019.
Joanna L. Stollings, Pharm.D., FCCM, FCCP, BCPS, BCCCP Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption and Neuromuscular Blockade in Adult Intensive Care Unit Patients Dr. Joanna L. Stollings is the Medical Intensive Care Unit Clinical Pharmacy Specialist at the Vanderbilt University Medical Center, Nashville, Tennessee. Dr. Stollings is the pharmacist for the Post ICU Recovery Center at Vanderbilt, Vanderbilt Center for Critical Illness, Brain Dysfunction and Survivorship, and Pragmatic Critical Care Research Group. She also is Affiliate Pharmacy Faculty at Belmont University College of Pharmacy, Lipscomb University College of Pharmacy, and University of Tennessee College of Pharmacy. Dr. Stollings graduated Summa Cum Laude from West Virginia University School of Pharmacy. She then completed a Pharmacy Practice Residency at Charleston Area Medical Center in Charleston, West Virginia and a Critical Care Pharmacy Residency at Mayo Clinic in Rochester, Minnesota. Dr. Stollings’s research interests include pharmacotherapy of agents used for analgesia, sedation, and delirium, non-pharmacologic methods used in the prevention of delirium, strategies to facilitate ventilator weaning, Post Intensive Care Syndrome, fluid resuscitation, and vasopressors. She has published over 70 peer reviewed publications and book chapters. Dr. Stollings is an active member of the Society of Critical Care Medicine in which serves as the chair elect for the Clinical Pharmacy and Pharmacology Section, member of THRIVE, and the ICU Liberation Collaboration in which she currently is the past co-chair. She is also an active member of the American College of Clinical Pharmacy in which she just served as the faculty panel chair for CCSAP and serves as faculty annually for the critical care board review.
Joseph M. Swanson, Pharm.D., FCCP, FCCM Pharmacokinetics/Pharmacodynamics Joseph M. Swanson is an associate professor of clinical pharmacy and an associate professor of pharmacology at the University of Tennessee College of Pharmacy and College of Medicine, respectively, in Memphis, Tennessee. Dr. Swanson received his Pharm.D. degree from the University of Tennessee in 2002. In 2003, he completed an American Society of Health-System Pharmacists (ASHP)-accredited pharmacy practice residency at the Regional Medical Center in Memphis, Tennessee. He furthered his training with a 1-year critical care/nutrition support specialty residency at the Elvis Presley Trauma Center in Memphis, Tennessee, and a 2-year critical care fellowship at the University of Tennessee. In 2006, Dr. Swanson joined the faculty at the University of Tennessee. Dr. Swanson has more than 35 peer-reviewed publications and 6 first-edition book chapters. His research interests include pharmacotherapy and infectious complications in critically ill patients, and he has served as the principal or coinvestigator for research funded through ASHP, the Society of Infectious Diseases Pharmacists, and the pharmaceutical industry. Dr. Swanson has given lectures related to critical care and infectious diseases at local, regional, and national meetings. He has been board certified in pharmacotherapy since 2005. He currently maintains a clinical practice at the level 1 trauma center (Elvis Presley Trauma Center) at Regional One Health in Memphis, Tennessee. He lectures to pharmacy students throughout the curriculum and is a preceptor in the trauma critical care APPEs.
Eljim P. Tesoro, Pharm.D., FCCM, FNCS, BCCCP Neurocritical Care Dr. Tesoro is a Clinical Associate Professor in the College of Pharmacy at the University of Illinois at Chicago and a clinical pharmacist in Neurosciences/Neurocritical Care at the University of Illinois Hospital & Health Sciences System. He received his Pharm.D. from the University of California at San Francisco. He completed a Pharmacy Practice Residency at the University of Illinois at Chicago and then went on to complete a two-year clinical fellowship in Critical Care at the Virginia Commonwealth University/Medical College of Virginia Campus. He currently serves as Director of the PGY2 Residency in Critical Care Pharmacy and is involved in residency training and education. He has authored numerous articles and written several textbook chapters and has lectured locally and internationally on critical care pharmacotherapy, hospital-acquired infections, epilepsy/status epilepticus, and ischemic/hemorrhagic stroke. He is a member of the Society of Critical Care Medicine, the Neurocritical Care Society, and the American Society of Health-Systems Pharmacists. He is a Fellow of the Neurocritical Care Society, a Fellow of the American College of Critical Care Medicine, is board-certified as a critical care pharmacist, and certified in Advanced Cardiac Life Support and Emergency Neurological Life Support. His areas of interest include nosocomial infections in the ICU, epilepsy, neuroprotection and acute CNS injury, and stroke.
Edward T. Van Matre, Pharm.D., M.S., BCCCP Research Design, Biostatistics, and Literature Evaluation
Kyle A. Weant, Pharm.D., FCCP, BCPS, BCCCP Toxicology Kyle A. Weant received his Pharm.D. degree from the University of North Carolina and completed his PGY1 and PGY2 residencies at the University of Kentucky. He has practiced as both a Neurosurgery and an Emergency Medicine Clinical Specialist and served as an Emergency Medicine PGY2 Program Director. He has also worked for Public Health Preparedness and Response, helping local, state, and the federal government better prepare for natural and man-made disasters. Currently, he is a Clinical Assistant Professor in the Department of Clinical Pharmacy and Outcomes Sciences at the University of South Carolina College of Pharmacy. He also maintains a clinical practice site in Emergency Medicine at Prisma Health Richland Hospital.
Diana Wells Mulherin, Pharm.D., BCNSP, BCCCP Fluids, Electrolytes, Acid-Base Disorders, and Nutrition Support Diana Mulherin is a Clinical Pharmacy Specialist in Nutrition Support at Vanderbilt University Medical Center in Nashville, Tennessee. She earned her Doctor of Pharmacy degree from the Medical University of South Carolina. She went on to complete a pharmacy practice residency at Palmetto Health Richland and critical care PGY2 at the University of Tennessee and the Regional Medical Center at Memphis. She is board certified in Nutrition Support and Critical Care. She joined the inpatient Adult Nutrition Support Team at Vanderbilt 5 years ago where her practice, research, and teaching efforts are focused on critical care nutrition. She has spoken professionally and authored several book chapters and journal articles on topics related to nutrition and critical care. Outside of her clinical responsibilities, Dr. Mulherin is an active member of the American Society for Parenteral and Enteral Nutrition and the Society of Critical Care Medicine. She serves on multiple committees within these organizations and has also held leadership positions within the Clinical Pharmacy and Pharmacology section of SCCM.
Adrian Wong, Pharm.D., M.P.H., FCCM, BCCCP Practice Administration and Development: Pharmacoeconomics and Safe Medication Use Adrian Wong, PharmD, MPH, FCCM, FCCP, BCCCP is a clinical pharmacy specialist in the medical ICU at Beth Israel Deaconess Medical Center in Boston, Massachusetts. He received his Doctor of Pharmacy at Northeastern University and a Master of Public Health from the Harvard T.H. Chan School of Public Health. He completed a pharmacy practice residency at The Johns Hopkins Hospital and a critical care pharmacy residency at the University of Pittsburgh Medical Center. He then completed an Outcomes Research and Pharmacy Informatics fellowship at Brigham and Women's Hospital/MCPHS University. His research interests include alcohol withdrawal syndrome, clinical decision support, informatics, and patient safety. Dr. Wong is an active member of the American College of Clinical Pharmacy, currently serving on a working group developing a commentary on the role of AI in clinical practice. He has been elected as a Fellow of the American College of Critical Care Medicine and the American College of Clinical Pharmacy.